Found: 5
Select item for more details and to access through your institution.
Possible risk of overestimation of renal function using cystatin C-based eGFR in testicular cancer survivors treated with cisplatin-based chemotherapy.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 3, p. 727, doi. 10.1007/s10157-017-1474-x
- By:
- Publication type:
- Article
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 4, p. 732, doi. 10.1007/s10157-016-1327-z
- By:
- Publication type:
- Article
Systemic transduction of p16<sup>INK4a</sup> antitumor peptide inhibits lung metastasis of the MBT-2 bladder tumor cell line in mice.
- Published in:
- Oncology Letters, 2019, v. 17, n. 1, p. 1203
- By:
- Publication type:
- Article
Long-term single-institute experience with trimodal bladder-preserving therapy with proton beam therapy for muscle-invasive bladder cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 1, p. 67, doi. 10.1093/jjco/hyw151
- By:
- Publication type:
- Article
Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study).
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 6, p. 1142, doi. 10.1007/s10147-016-1007-8
- By:
- Publication type:
- Article